Express Scripts Holding Company (NASDAQ:ESRX) Releases Report On ADHD Drug Use Which Continues To Climb

Boston, MA, 03/13/2014 – Express Scripts Holding Company (NASDAQ:ESRX) released its analysis of ADHD medications yesterday. According to the report, the number of Americans who take medication to treat ADHD increased as much as 36% in 5 years.

Highest Use Among Adult Women

Express Scripts Holding Company (NASDAQ:ESRX) reported its most recent and comprehensive analysis of the medications related to ADHD or Attention Deficit Hyperactivity Disorder in its report called ‘Turning Attention to ADHD’. According to the findings stated in the report, the greatest surge in the intake of these drugs in the five year analysis period was marked in adults. Among these adults, the largest gains were noticed in women in the age range of 26 to 34 years, whose ratio of increase was as high as 85%.

In contrast to the trend seen in adults, among children, girls who take medications for ADHD account for only half the number of boys who are prescribed with these drugs. After the age of 18, the number of male candidates for the drug plunges whereas women of age from 19 to 25 increases in number as compared to younger ones. Use of the drugs among younger buys of ages between 12 and 18 decreased from 18% in 2012 to 9%.

Prevalent In Southern Regions

It was also found that the southern part of the U.S. has the highest concentration of ADHD drugs use. In South Carolina, the effect was the strongest, where 14% of the population of age between 12 and 18 years are undergoing ADHD treatments. Another finding of the report marks that antipsychotic treatments are more common among those who are already being treated for ADHD.

The research was based on de-identified pharmacy claims of as many as 400,000 privately insured people of age lower than 65. The analysis covered trends in use, price and the use of the concurrent treatments such as antidepressants, behavioral therapy and antipsychotics.

Like it? Share it!

Leave A Response